Skip to main content
. 2023 Jul 28;131(7):077010. doi: 10.1289/EHP12215

Table 4.

Associations of air pollutants with risk of gastrointestinal cancer in individuals with IBD, CD, and UC in the UK Biobanks Study, mean follow-up of 12 y.

Air pollutants in quartiles (μg/m3) IBD (n=4,708) CD (n=1,485) UC (n=3,233)
Cases/person-years HR (95% CI)a p-Value HR (95% CI)b p-Valuec Cases/person-years HR (95% CI)b p-Value Cases/person-years HR (95% CI)b p-Value
NOx
 Per IQR (15.6) 0.98 (0.82, 1.18) 0.843 0.98 (0.81, 1.18) 0.807 0.86 (0.56, 1.31) 0.479 1.03 (0.83, 1.28) 0.782
 Q1 (19.7 to<34.8) 34/14,031 Ref Ref 6/4,486 Ref 28/9,493 Ref
 Q2 (34.8 to<42.0) 24/13,964 0.73 (0.43, 1.22) 0.229 0.71 (0.42, 1.20) 0.201 7/4,241 1.36 (0.45, 4.11) 0.591 17/9,697 0.59 (0.32, 1.09) 0.090
 Q3 (42.0 to<50.4) 39/13,865 1.16 (0.73, 1.85) 0.521 1.16 (0.73, 1.85) 0.523 14/4,507 2.64 (1.00, 7.00) 0.053 25/9,207 0.90 (0.52, 1.55) 0.695
 Q4 (50.4–247.5) 27/14,121 0.89 (0.54, 1.46) 0.640 0.87 (0.52, 1.44) 0.587 2/4,282 0.43 (0.08, 2.14) 0.299 25/9,722 0.96 (0.56, 1.64) 0.873
p-Trend 0.893 0.926 0.999 0.825
NO2
 Per IQR (10.4) 1.04 (0.85, 1.28) 0.695 1.03 (0.84, 1.27) 0.745 0.91 (0.58, 1.44) 0.689 1.09 (0.86, 1.37) 0.487
 Q1 (10.0 to<23.0) 34/13,958 Ref Ref 6/4,564 Ref 28/9,357 Ref
 Q2 (23.0 to<27.9) 28/14,003 0.84 (0.51, 1.39) 0.495 0.84 (0.51, 1.38) 0.485 9/4,215 1.75 (0.61, 4.98) 0.295 19/9,665 0.68 (0.38, 1.21) 0.190
 Q3 (27.9 to<33.4) 30/14,094 0.90 (0.55, 1.47) 0.681 0.92 (0.56, 1.51) 0.738 10/4,428 1.87 (0.67, 5.24) 0.233 20/9,560 0.72 (0.41, 1.29) 0.272
 Q4 (33.4–86.6) 32/13,926 1.02 (0.63, 1.65) 0.947 1.01 (0.62, 1.64) 0.971 4/4,308 0.86 (0.24, 3.11) 0.819 28/9,538 1.04 (0.61, 1.77) 0.874
p-Trend 0.900 0.897 0.992 0.845
PM10
 Per IQR (2.3) 1.00 (0.81, 1.24) 0.990 1.00 (0.81, 1.24) 0.995 0.79 (0.49, 1.25) 0.312 1.09 (0.86, 1.39) 0.488
 Q1 (13.7 to<18.0) 33/14,017 Ref Ref 11/4,270 Ref 22/9,672 Ref
 Q2 (18.0 to<19.1) 30/14,185 0.91 (0.55, 1.48) 0.694 0.91 (0.55, 1.50) 0.711 7/4,648 0.58 (0.22, 1.50) 0.261 23/9,451 1.08 (0.60, 1.93) 0.807
 Q3 (19.1 to<20.3) 31/13,985 0.98 (0.60, 1.60) 0.929 0.98 (0.60, 1.60) 0.941 8/4,358 0.78 (0.31, 1.97) 0.602 23/9,512 1.09 (0.60, 1.95) 0.780
 Q4 (20.3–28.6) 30/13,794 0.97 (0.59, 1.59) 0.899 0.96 (0.58, 1.58) 0.868 3/4,239 0.31 (0.09, 1.14) 0.097 27/9,485 1.29 (0.73, 2.28) 0.375
p-Trend 0.974 0.943 0.120 0.390
PM2.5
 Per IQR (1.3) 0.98 (0.79, 1.21) 0.824 0.97 (0.78, 1.20) 0.789 0.89 (0.57, 1.40) 0.624 1.01 (0.79, 1.30) 0.920
 Q1 (8.2 to<9.3) 35/14,077 Ref Ref 9/4,573 Ref 26/9,427 Ref
 Q2 (9.3 to<9.9) 27/13,898 0.78 (0.47, 1.29) 0.331 0.76 (0.46, 1.26) 0.295 6/4,372 0.82 (0.29, 2.36) 0.713 21/9,489 0.77 (0.43, 1.37) 0.372
 Q3 (9.9 to<10.6) 35/13,898 1.03 (0.65, 1.65) 0.886 1.03 (0.65, 1.66) 0.887 9/4,245 1.30 (0.50, 3.35) 0.593 26/9,549 0.99 (0.57, 1.71) 0.977
 Q4 (10.6–20.7) 27/14,108 0.82 (0.50, 1.36) 0.438 0.80 (0.48, 1.33) 0.394 5/4,325 0.69 (0.23, 2.12) 0.521 22/9,654 0.85 (0.48, 1.50) 0.573
p-Trend 0.698 0.97 (0.82, 1.13) 0.662 0.786 0.788

Note: —, no data; BMI, body mass index; CD, Crohn’s disease; CI, confidence interval; HR, hazard ratio; IBD, inflammatory bowel disease; IQR, interquartile range; NO2, nitrogen dioxide; NOx, nitrogen oxides; PM, particulate matter; PM2.5 PM with aerodynamic diameter 2.5μm; PM10, PM with aerodynamic diameter 10μm; Ref, reference; UC, ulcerative colitis.

a

Based on Cox proportional model adjusted for age, sex, ethnicity.

b

Based on Cox proportional model adjusted for age, sex, ethnicity, assessment centers, household income, smoking status, education, BMI, physical activity, healthy diet, alcohol consumption, baseline related surgery history, medication (use of nonsteroidal anti-inflammatory drugs, amino salicylates, corticosteroids, and immunomodulators).

c

p-Value <0.05 was considered statistically significant.